Analysts expect Biovie Inc. to report revenue of 0.00 for Q1 25, against a range of 0.00 to 0.00. The most recent reported quarter, Q4 25, came in at 0.00.
| Metric | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 | Q1 31 | Q2 31 | Q3 31 | Q4 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | |||||||||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 81,214.48 | -715.65 | -31,518.39 | |||||||||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 73,788.88 | -835.43 | -38,478.37 | |||||||||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 77,501.68 | -775.54 | -34,998.38 |
Analysts expect Biovie Inc. to report earnings per share of -15.39 for Q1 25, against a range of -16.87 to -13.91. The most recent reported quarter, Q4 25, came in at -1.82, a 7.1% miss against the -1.70 consensus.
| Metric | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 | Q1 31 | Q2 31 | Q3 31 | Q4 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | -4.60 | -1.51 | -1.82 | - | - | - | - | - | - | - | |||||||||||||||||
| High Estimate | -13.91 | -15.76 | -1.29 | -1.60 | -0.91 | -0.73 | -0.70 | -0.49 | 0.32 | 1.35 | -0.52 | |||||||||||||||||
| Low Estimate | -16.87 | -17.42 | -1.55 | -1.80 | -1.01 | -0.79 | -0.82 | -0.59 | 0.28 | 1.13 | -0.62 | |||||||||||||||||
| Consensus Estimate | -15.39 | -16.59 | -1.42 | -1.70 | -0.96 | -0.76 | -0.76 | -0.54 | 0.30 | 1.24 | -0.57 |